| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.98B | 28.86B | 20.97B | 15.25B | 13.16B | 11.69B |
| Gross Profit | 4.26B | 8.23B | 5.83B | 2.68B | 2.85B | 2.57B |
| EBITDA | 2.31B | 6.13B | 3.91B | 1.16B | 1.03B | 909.01M |
| Net Income | 1.44B | 4.33B | 2.55B | 808.85M | 539.99M | 323.48M |
Balance Sheet | ||||||
| Total Assets | 25.47B | 33.09B | 25.04B | 20.45B | 17.47B | 17.04B |
| Cash, Cash Equivalents and Short-Term Investments | 5.06B | 7.41B | 4.28B | 4.26B | 4.09B | 2.89B |
| Total Debt | 3.26B | 4.74B | 3.21B | 2.65B | 3.76B | 4.09B |
| Total Liabilities | 17.09B | 19.21B | 15.29B | 13.10B | 10.91B | 10.83B |
| Stockholders Equity | 8.37B | 13.88B | 9.75B | 7.34B | 6.55B | 6.21B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.41B | -293.40M | 1.44B | 1.60B | -1.12B |
| Operating Cash Flow | 0.00 | 6.75B | 391.13M | 2.50B | 1.80B | -76.45M |
| Investing Cash Flow | 0.00 | -4.70B | -761.91M | -1.06B | -269.69M | -1.06B |
| Financing Cash Flow | 0.00 | 1.08B | 389.47M | -1.26B | -247.81M | 144.55M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥72.32B | 9.50 | ― | 2.63% | -6.00% | -13.74% | |
75 Outperform | ¥114.59B | 19.34 | ― | 0.55% | 9.04% | -7.84% | |
75 Outperform | ¥65.23B | 13.24 | ― | 3.95% | -1.67% | -4.39% | |
73 Outperform | ¥19.01B | 20.01 | ― | 2.78% | 38.48% | 100.84% | |
71 Outperform | ¥56.82B | 10.14 | 11.47% | 1.88% | -0.04% | 15.59% | |
70 Outperform | ¥69.96B | 4.09 | ― | 3.09% | 6.35% | -34.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |